Outset Medical, Inc. engages in the provision of dialysis solutions to patients and healthcare providers. The company is headquartered in San Jose, California and currently employs 310 full-time employees. The company went IPO on 2020-09-15. The company offers Tablo Hemodialysis System (Tablo), which is a single enterprise solution for hemodialysis, comprised of a compact console with integrated water purification, on-demand dialysate production and advanced software and connectivity capabilities. The company designed Tablo from the ground up to be a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere, and by virtually anyone. Tablo comprises various components, including Tablo Console, Tablo Cartridge, and Tablo Data Ecosystem. Tablo Console is a proprietary, compact, mobile and versatile machine consisting of an integrated water purification, on-demand dialysate production system and simple-to-use touchscreen interface with 3D animations. The company also offers various key platforms, such as TabloHub, a customer-facing portal; MyTablo, a patient-facing portal, and TabloDash, an internal data analytics platform.
Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Revenue
119
119
113
130
115
102
Revenue Growth (YoY)
5%
5%
-13%
13%
13%
108%
Cost of Revenue
72
72
75
101
97
95
Gross Profit
46
46
38
29
17
7
Selling, General & Admin
92
92
110
141
130
101
Research & Development
21
21
36
57
48
36
Operating Expenses
113
113
146
198
178
138
Other Non Operating Income (Expenses)
--
--
--
--
0
0
Pretax Income
-80
-80
-127
-172
-162
-131
Income Tax Expense
0
0
0
0
0
0
Net Income
-81
-81
-127
-172
-163
-131
Net Income Growth
-36%
-36%
-26%
6%
24%
66%
Shares Outstanding (Diluted)
18.16
15.21
3.46
49.58
48.16
45.58
Shares Change (YoY)
416%
339%
-93%
3%
6%
7%
EPS (Diluted)
-4.49
-5.36
-36.95
-3.48
-3.38
-2.89
EPS Growth
-88%
-85%
961.99%
3%
17%
55%
Free Cash Flow
-47
-47
-117
-134
-154
-133
Free Cash Flow Per Share
--
--
--
--
--
--
Gross Margin
38.65%
38.65%
33.62%
22.3%
14.78%
6.86%
Operating Margin
-55.46%
-55.46%
-95.57%
-130%
-140%
-127.45%
Profit Margin
-68.06%
-68.06%
-112.38%
-132.3%
-141.73%
-128.43%
Free Cash Flow Margin
-39.49%
-39.49%
-103.53%
-103.07%
-133.91%
-130.39%
EBITDA
-62
-62
-103
-164
-156
-125
EBITDA Margin
-52.1%
-52.1%
-91.15%
-126.15%
-135.65%
-122.54%
D&A For EBITDA
4
4
5
5
5
5
EBIT
-66
-66
-108
-169
-161
-130
EBIT Margin
-55.46%
-55.46%
-95.57%
-130%
-140%
-127.45%
Effective Tax Rate
0%
0%
0%
0%
0%
0%
Follow-Up Questions
What are Outset Medical Inc's key financial statements?
According to the latest financial statement (Form-10K), Outset Medical Inc has a total asset of $264, Net loss of $-81
What are the key financial ratios for OM?
Outset Medical Inc's Current ratio is 1.92, has a Net margin is -68.06, sales per share of $7.82.
How is Outset Medical Inc's revenue broken down by segment or geography?
Outset Medical Inc largest revenue segment is Consumables, at a revenue of 51,145,000 in the most earnings release.For geography, United States is the primary market for Outset Medical Inc, at a revenue of 113,689,000.
Is Outset Medical Inc profitable?
no, according to the latest financial statements, Outset Medical Inc has a net loss of $-81
Does Outset Medical Inc have any liabilities?
yes, Outset Medical Inc has liability of 137
How many outstanding shares for Outset Medical Inc?
Outset Medical Inc has a total outstanding shares of 18.16